Even though by definition the heterozygous carriers should not show any clinical disease manifestation, study by Gunay-Aygun et al. [35] suggests that individuals who are heterozygous for PKHD1 mutations have an increased risk of polycystic liver disease and mild PKD. Here, PKHD1 is linked to Isolated polycystic liver disease.